Search for Clinical Trial Results
Ocular Melanoma - 50 Studies Found
Status | Study |
Terminated |
Study Name: A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma Condition: Uveal Melanoma Date: 2013-02-21 Interventions:
|
Not yet recruiting |
Study Name: Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma Condition: Uveal Melanoma Date: 2017-02-14 Interventions:
|
Active, not recruiting |
Study Name: Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma Condition: Uveal Melanoma Date: 2015-12-01 Interventions:
|
Recruiting |
Study Name: A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma Condition: Uveal Melanoma Date: 2015-10-06 Interventions: Drug: IMCgp100 Bispecific soluble HLA-A2 restricted gp100-specific TCR fused to anti-CD3 |
Recruiting |
Study Name: Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0) Condition: Uveal Melanoma Date: 2016-07-13 Interventions: Biological: Blood sampling 7,5 ml of patient peripherical blood will be collected at each blood sample. |
Completed |
Study Name: Study of Metastatic Ocular Melanoma Condition: Ocular Melanoma Date: 2005-09-09 Interventions:
|
Active, not recruiting |
Study Name: STA-9090(Ganetespib) in Metastatic Ocular Melanoma Condition: Ocular Melanoma Date: 2010-09-10 Interventions: Drug: STA-9090 Given intravenously once week or twice a week for three weeks of a four week cycle |
Recruiting |
Study Name: Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma Condition: Ocular Melanoma Date: 2013-07-02 Interventions:
|
Withdrawn |
Study Name: Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye Condition: Ocular Melanoma Date: 2008-02-11 Interventions:
|
Active, not recruiting |
Study Name: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma Condition:
Date: 2013-03-15 Interventions:
|